Host cell genomic and transcriptional machinery

The host cell genomic and transcriptional machinery refers to the integrated system of enzymes and proteins—including RNA polymerases, DNA polymerases, and transcription factors—that facilitate the replication and expression of the host genome (Source: NIH, National Library of Medicine). This machinery is a critical interface in infectious diseases, as viruses are obligate intracellular parasites that must hijack these host processes to synthesize viral mRNA and replicate their genetic material (Source: Nature Reviews Microbiology, "Viral Hijacking of Host Cell Machinery"). In oncology, the transcriptional machinery is often dysregulated, leading to "transcriptional addiction" where cancer cells become overly dependent on specific transcriptional regulators for survival (Source: PubMed, "Transcriptional dependencies in cancer"). Therapeutic strategies targeting this machinery include the use of CDK inhibitors like Flavopiridol and HDAC inhibitors like Vorinostat to modulate gene expression (Source: National Cancer Institute). However, because these processes are essential for normal cellular homeostasis, targeting them presents significant safety challenges, including systemic toxicity and a narrow therapeutic index (Source: StatPearls, "Chemotherapy Side Effects").

Other names

Host cell machineryCellular transcriptional apparatusHost transcriptional machineryHost genomic machineryHost cell transcriptional machinery

Inhibition of host RNA polymerases, inhibition of cyclin-dependent kinases (CDKs) involved in transcription, and modulation of epigenetic states through histone deacetylase (HDAC) inhibition.